BlackRock Advisors’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$13.7M Buy
1,390,733
+1,143,027
+461% +$11.3M 0.01% 702
2016
Q3
$2.99M Buy
247,706
+17,990
+8% +$217K ﹤0.01% 1269
2016
Q2
$1.98M Buy
229,716
+2,611
+1% +$22.5K ﹤0.01% 1402
2016
Q1
$2.15M Buy
227,105
+3,118
+1% +$29.5K ﹤0.01% 1355
2015
Q4
$3.88M Sell
223,987
-41,319
-16% -$716K ﹤0.01% 1159
2015
Q3
$3.56M Buy
265,306
+91,739
+53% +$1.23M ﹤0.01% 1179
2015
Q2
$3.92M Buy
173,567
+80,381
+86% +$1.81M ﹤0.01% 1034
2015
Q1
$1.33M Buy
93,186
+36,125
+63% +$516K ﹤0.01% 1378
2014
Q4
$551K Sell
57,061
-44,290
-44% -$428K ﹤0.01% 1903
2014
Q3
$922K Buy
101,351
+30,739
+44% +$280K ﹤0.01% 1452
2014
Q2
$698K Sell
70,612
-32,115
-31% -$317K ﹤0.01% 1734
2014
Q1
$1.31M Buy
102,727
+43,565
+74% +$553K ﹤0.01% 1349
2013
Q4
$887K Buy
59,162
+4,183
+8% +$62.7K ﹤0.01% 1566
2013
Q3
$607K Buy
54,979
+1,273
+2% +$14.1K ﹤0.01% 1752
2013
Q2
$427K Buy
+53,706
New +$427K ﹤0.01% 1941